No effective therapy is available for advanced hepatocellular carcinoma (liver cancer), it’s a terminal condition. Over 18,000 people typically die from it in the USA each year. It is much more common in Africa and East Asia where the risk of infection from Hepatitis B and C is much higher, which are associated with increased [...]
Entries Tagged as 'liver cancer'
Improving survival in Liver Cancer – at what cost?
July 28th, 2008 · No Comments · cancer, competitive intelligence, health, liver cancer, market trends, oncology, pharma, strategy
Tags:
New treatment option for patients with liver cancer
July 2nd, 2008 · No Comments · FLT3, VEGF inhition, c-Kit, cancer, competitive intelligence, liver cancer, market intelligence, market trends, oncology
Treatment with sunitinib (Sutent) slows tumour growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver. Hepatocellular carcinoma is a cancer that relies heavily on blood vessels for growth; sunitinib controls the growth of blood vessels and could therefore potentially play an important role for treatment. Image [...]
Tags: